Google's Life Sciences division is investing its resources in order to provide better lives to people living with diabetes. Earlier this week, Google Life Sciences unit announced that diabetes will be the company's first major disease target.

Google Life Sciences unit is working on new initiatives with an aim to help people having diabetes live better lives. The unit has been investing its resources in accomplishing this task and has also announced that diabetes will be its first major disease target.

Jacquelyn Miller, Google Life Sciences spokeswoman, said it is very tough for people having diabetes to manage their blood sugar. Michael Chae, executive director of the San Francisco Bay Area Chapter at the American Diabetes Association, said it is not tough to figure out as to why Google is having interest in this field.

Miller said the total cost of managing diabetes was $245 billion in 2012 in America alone. Second important factor is the timing is very correct for the technology company to enter the field.

Chae said so many advancements have been made in the medicine field that now people with diabetes are more comfortable living in a measurable world. Chae envisions a time when people will be able to manage their blood glucose levels on a continuous basis and through painless methods.

Google life sciences unit's head molecular biologist Andy Conrad is taking things to a different level. He has helped company secure partnership with top drug makers and medical device companies. Google is also working with Johnson & Johnson on surgical robots, also with Biogen on potential treatments for multiple sclerosis and Novartis and Dexcom diabetes-related projects.